Following the signing of the final agreement with Primonial REIM and the minority shareholders of Icade Santé and Icade Healthcare Europe (IHE) on the sale of the entire healthcare portfolio by 2025 on 13 June, Icade announced on 5 July that it completed the first stage of the transaction: the sale of 63% of its stake in Icade Santé for a total of €1.4bn.
I am delighted to announce that the first stage of the sale of our Healthcare business has been completed. The teams at Icade have worked very hard over the past few months to bring it about. This important transaction for the Group will allow us to further reinforce our balance sheet and define a roadmap adapted to the new reality in the financial and real estate markets.
Nicolas Joly, CEO of Icade